Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-Abdominal Abscesses - No Study Results Posted

Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-Abdominal Abscesses (MEMO)

This study is currently recruiting participants.

Study NCT00629135 Information provided by Hannover Medical School

First Received: February 25, 2008 Last Updated: March 4, 2008 History of Changes

No Study Results Posted or ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	August 2009
Estimated Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)